The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORM.L Regulatory News (ORM)

  • There is currently no data for ORM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Aquis Growth Market

4 Sep 2023 08:28

RNS Number : 2667L
Ormonde Mining PLC
04 September 2023
 

4 September 2023

 

Ormonde Mining plc

("Ormonde" or the "Company")

 

Admission to Aquis Growth Market

 

Ormonde Mining plc (AQSE: ORM) is pleased to announce that 472,507,482 ordinary shares of €0.01 each in the Company ("Ordinary Shares") have today been admitted to the Access Segment of the Aquis Growth Market ("Admission").

 

The Ordinary Shares have been suspended from trading on the AIM and Euronext Growth markets since 7 February 2023, and admission of the Ordinary Shares to those markets will be cancelled with effect from 07.00 a.m. on 5 September 2023 ("Cancellation"). Dealings in the Ordinary Shares on the Aquis Growth Market are expected to commence at 08.00 a.m. on 5 September 2023.

 

 Ordinary Share Information

 

· ISIN: IE00BF0MZF04

· TIDM: ORM

· SEDOL: BF0MZG1

 

Note: the ISIN, TIDM and SEDOL of the Company have not changed. 

 

About Ormonde

 

With effect from 5 September 2023, Ormonde will own an initial 36.2% controlling interest (under TSXV Rules) in TRU Precious Metals Corp. (TSXV: TRU) ("TRU"), which is exploring for gold and copper in the highly prospective Central Newfoundland Gold Belt in Canada. Ormonde's funding will be used to fast-track the advancement of TRU's Golden Rose Project as well as the evaluation of other mineral property transaction opportunities.

 

Ormonde also owns a 20% interest in Peak Nickel Limited, which is advancing exploration on a potentially significant battery metals project.

 

After Admission, the Company intends to monitor its existing investments, working with incumbent management to generate maximum value from them. The Directors will also consider additional investment opportunities as they arise.

 

Further information about the Company is available on its website at www.ormondemining.com.

 

Significant shareholding

The Company has been notified of the following holding which will, on Admission, represent more than 3% of the issued Ordinary Shares:

 

Shareholder

% of Issued Share Capital

Thomas Anderson

24.99

 

Total Voting Rights

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, Ormonde has 472,507,482 Ordinary Shares in issue. This figure of 472,507,482 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

This announcement, together with any documents incorporated by reference, shall be deemed to constitute an admission document for the purposes of the Aquis Growth Market Rules for Issuers - Access. It has not been approved or reviewed by the Aquis Stock Exchange or the Financial Conduct Authority.

 

For further information, please contact:

Ormonde Mining plc Brian Timmons, Chairman

Tel: +353 (0)1 801 4184

Vigo Consulting (Investor Relations) Ben Simons / Fiona Hetherington

Tel: +44 (0)20 7390 0230

Peterhouse Capital (Aquis Corporate Adviser) Narisha Ragoonanthun / Brefo Gyasi

Tel: +44 (0)20 7469 0930

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCLIMRTMTTMMIJ
Date   Source Headline
5th Sep 20237:00 amRNSTrading on Aquis Growth Market
5th Sep 20237:00 amRNSCancellation - ORMONDE MINING PLC
4th Sep 20238:28 amRNSAdmission to Aquis Growth Market
25th Aug 20233:33 pmRNSResult of EGM & AGM
31st Jul 20236:26 pmRNSNotice of EGM & AGM
27th Jul 20236:19 pmRNSProposed Cancellation of Trading on AIM & Euronext
30th Jun 20236:27 pmRNSInvestment in TRU Precious Metals Corp.
27th Jun 20236:20 pmRNSFinal Results
8th Feb 20236:00 pmRNSOrmonde Mining
7th Feb 20237:30 amRNSSuspension - Ormonde Mining plc
7th Feb 20237:00 amRNSInvestment & Suspension of Listing
13th Jan 20234:40 pmRNSSecond Price Monitoring Extn
13th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Oct 202211:11 amRNSCompletion of Sale of La Zarza Assets
28th Sep 20221:15 pmRNSResult of AGM & EGM
28th Sep 20227:00 amRNSHalf-year Report
30th Aug 20223:24 pmRNSPublication of EGM Circular
29th Jul 20227:00 amRNSSale of La Zarza & Notice of EGM
27th Jun 20227:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20227:00 amRNSFinal Results
24th Dec 20211:19 pmRNSHolding(s) in Company
30th Nov 20217:00 amRNSAppointment of CEO
19th Nov 20217:00 amRNSGrant of Options
4th Oct 20217:00 amRNSBoard Roles and Disclosures for New Directors
30th Sep 20213:29 pmRNSResult of AGM
23rd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSAGM Update
14th Jul 20217:00 amRNSAdjourned AGM
1st Jul 20214:40 pmRNSSecond Price Monitoring Extn
1st Jul 20214:35 pmRNSPrice Monitoring Extension
1st Jul 20212:05 pmRNSSecond Price Monitoring Extn
1st Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20219:50 amRNSAGM Update
29th Jun 20217:00 amRNSAGM - Director Requisitions
24th Jun 20214:40 pmRNSSecond Price Monitoring Extn
24th Jun 20214:35 pmRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSAnnual Report & Notice of AGM
26th May 20217:00 amRNSHolding(s) in Company
26th May 20217:00 amRNSFinal Results
7th Apr 20219:05 amRNSSecond Price Monitoring Extn
7th Apr 20219:00 amRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20212:43 pmRNSUpdate on Acquisition
23rd Mar 20214:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20214:36 pmRNSPrice Monitoring Extension
23rd Mar 20219:05 amRNSSecond Price Monitoring Extn
23rd Mar 20219:00 amRNSPrice Monitoring Extension
12th Mar 20215:00 pmRNSUpdate on Migration
3rd Mar 20214:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.